Lan Phuong Vu1, Michael Gütschow1. 1. Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany.
Abstract
Diketomorpholines (DKMs; morpholine-2,5-diones) possess a six-membered ring with a lactone and lactam moiety and belong to the family of cyclodepsipeptides. In this review, the synthetic accessibility of DKMs is summarized and their utilization, in particular, for ring-opening polymerization reactions, is highlighted. The occurrence of the DKM scaffold in natural products encompasses small monocyclic compounds but also complex, polycyclic representatives with a fused DKM ring.
Diketomorpholines (DKMs; morpholine-2,5-diones) possess a six-membered ring with a lactone and lactam moiety and belong to the family of cyclodepsipeptides. In this review, the synthetic accessibility of DKMs is summarized and their utilization, in particular, for ring-opening polymerization reactions, is highlighted. The occurrence of the DKM scaffold in natural products encompasses small monocyclic compounds but also complex, polycyclic representatives with a fused DKM ring.
Diketomorpholines (DKMs;
morpholine-2,5-diones) constitute derivatives
of the heterocyclic structure 1 (Figure ). DKMs bear one lactam and one lactone moiety,
which occur each two-fold in highly abundant diketopiperazines 2 and glycolides 3, respectively (Figure ). With the lactam and lactone
group in the same six-membered ring, DKMs can be regarded as the simplest
members of the large family of cyclodepsipeptides and are also referred
to as cyclodepsidipeptides.[1] In this review,
a comprehensive overview on the synthetic access to DKMs is given,
and some remarkable applications and the occurrence of the DKM scaffold
in natural products are described.
Figure 1
General structures of diketomorpholines
(1), diketopiperazines
(2), and substituted glycolides (3).
General structures of diketomorpholines
(1), diketopiperazines
(2), and substituted glycolides (3).
Solution-Phase Syntheses
In the following, recent and representative examples showing the
synthetic access to DKMs will be summarized (Schemes and 2). In both schemes,
only one possible configuration for the two chiral carbons is shown.
However, not only the depicted (3S,6S)-configured products have been prepared by the different outlined
methods, but also diastereomers with other defined configurations,
racemic products, as well as achiral compounds 1 and 10, in which R1 and R2 are hydrogens.
Further protocols employed for DKM synthesis are summarized elsewhere.[1]
Scheme 1
Synthetic Entries to DKMs from Hydroxyacyl
or Haloacyl Derivatives
Reagents and conditions: (a)
DMAP, BOP reagent, CH2Cl2,[2] or MeSO3H, CHCl3, Δ;[3] (b) DEAD, THF;[2] (c)
Amberlyst 15, toluene, Δ,[2] or p-TsOH, toluene, Δ;[4,5] (d) p-TsOH, toluene, Δ,[4] or
DBU, MS 4 Å, toluene;[6] (e) NaHCO3, DMF, Δ,[7,8] or TEA, DMF, Δ,[2,9] or DIPEA, CHCl3, Δ,[10] or (1) NaOH, EtOH, H2O, (2) H2SO4;[2] (f) DIPEA, DMSO,[11] or (1) K2CO3, H2O, (2)
HCl,[12] or (1) NaOH, EtOH, H2O, (2) HCl.[2]
Scheme 2
Synthetic
Entries to DKMs from Aminoacyl Derivatives
Reagents
and conditions: (a)
2-chloro-1-methylpyridinium iodide, DIPEA, CH2Cl2,[13] or 2-chloro-1-methylpyridinium iodide,
TEA, CH2Cl2;[13] (b)
piperidine, DMF,[13] DMAP, pyridine, Δ.[13]
Synthetic Entries to DKMs from Hydroxyacyl
or Haloacyl Derivatives
Reagents and conditions: (a)
DMAP, BOP reagent, CH2Cl2,[2] or MeSO3H, CHCl3, Δ;[3] (b) DEAD, THF;[2] (c)
Amberlyst 15, toluene, Δ,[2] or p-TsOH, toluene, Δ;[4,5] (d) p-TsOH, toluene, Δ,[4] or
DBU, MS 4 Å, toluene;[6] (e) NaHCO3, DMF, Δ,[7,8] or TEA, DMF, Δ,[2,9] or DIPEA, CHCl3, Δ,[10] or (1) NaOH, EtOH, H2O, (2) H2SO4;[2] (f) DIPEA, DMSO,[11] or (1) K2CO3, H2O, (2)
HCl,[12] or (1) NaOH, EtOH, H2O, (2) HCl.[2]
Synthetic
Entries to DKMs from Aminoacyl Derivatives
Reagents
and conditions: (a)
2-chloro-1-methylpyridinium iodide, DIPEA, CH2Cl2,[13] or 2-chloro-1-methylpyridinium iodide,
TEA, CH2Cl2;[13] (b)
piperidine, DMF,[13] DMAP, pyridine, Δ.[13]DKMs are available through
cyclative lactonizations (Scheme ). For the ring-closure reactions,
precursors 4–9 have been utilized,
all of which already contain a central amide bond. In the resulting
product structures 1 and 10, it appears
as an unsubstituted or substituted lactam moiety, respectively. The
formation of the lactone bond from free acids 4 or 5 was accomplished either by proton-catalyzed condensations
or in the presence of coupling reagents or under Mitsunobu conditions.
Acid- or base-promoted conversions of the esters 6 or 7 produced products 1 and 10 in
the course of interesterifications. Furthermore, halogen-substituted
educts 8 or 9 were employed for lactone
generation under basic conditions. In some cases, ester progenitor
compounds were saponified to the corresponding acids 8 or 9 prior to the cyclocondensation.As a second
opportunity, educts 11 and 12 with a preformed
central ester group have been subjected to lactamization,
leading to cyclized products 1 and 10 (Scheme ). The conversions
include the successful application of the Mukaiyama reagent. Typically,
the terminal amino group was deprotected before the cyclization occurred.Macrocyclic analogues of DKMs have been prepared from lactams bearing
an ε-hydroxyacyl residue at the cyclic nitrogen atom. Attack
of the terminal oxygen at the ring carbonyl led to side-chain insertion
to bicyclic cyclols, and the subsequent ring expansion gave monocyclic
products which represent macrocyclic counterparts of DKMs 1.[14]Recently, in a study on macrocyclo-oligomerizations,
it was observed
that the tetradepsipeptide 13 underwent an intramolecular
attack of the carboxylate at the central ester, leading to an anhydride
isomer 14, followed by fragmentation due to the nucleophilic
attack of the alcoholic group and generation of the protected compound 15 and DKM 16 (Scheme ).[15]
Scheme 3
Proposed
Mechanism for the Self-Cleavage of a Tetradepsipeptide
Scheme shows ester-based
prodrugs (17) of glucagon-like peptide 1 (GLP) in its
biologically active form GLP(7–36) and fused to peptide CEX,
a nine-amino-acid C-terminal extension.[16] The N-terminal phenylalanine was replaced with phenyllactic acid,
and the prodrugs dissociate under physiological conditions through
formation of DKMs 1 and liberate the active peptide 18.
Scheme 4
Hydroxy-Mediated Ester Cleavage of GLP Prodrugs (pH
7.4, 37 °C)
Solid-Phase
Syntheses
DKMs are accessible through various polymer-supported
methods.[17] Cyclization of resin-bound bromides 19 (Scheme ) was induced
by treatment with TFA, initially leading to cleavage from the Wang
resin, followed by ring closure to DKMs (R1 = H or alkyl,
R2 = alkyl).[18] A resin which
consisted of polyethylene glycol attached to cross-linked polystyrene
through an ether linkage was employed for DKM synthesis.[18] Here, the resin-bound structure 20 (R1 = alkyl, R2 = alkyl) was assembled by
Ugi reaction, and the NR3 portion of the products corresponded
to the structure of amino acid amides with R3 = CH(alkyl)CONH(cyclohexyl).
Scheme 5
General Entries to DKMs via Solid-Phase Synthesis
Reagents
and conditions: (a)
TFA (Wang resin);[18] (b) TEA, CH2Cl2 (TentaGel resin).[18] Racemic
mixtures were applied,[18] and only single
(S,S)-configured stereoisomers are
depicted here.
General Entries to DKMs via Solid-Phase Synthesis
Reagents
and conditions: (a)
TFA (Wang resin);[18] (b) TEA, CH2Cl2 (TentaGel resin).[18] Racemic
mixtures were applied,[18] and only single
(S,S)-configured stereoisomers are
depicted here.DKM precursors were coupled
to the polymer matrix via a photolabile
5-bromo-7-nitroindoline moiety (21), and alanine, leucine,
and phenylalanine-based DKMs 22 were produced in the
course of an intramolecular photoinduced cyclorelease (Scheme ).[19]
Scheme 6
Photoinduced Cleavage of DKMs from the Resin
The resin-bound structure 23 was produced by loading tert-butyl serine, deprotection, alkylation with bromoketones,
and acylation (Scheme ).[11] TFA-mediated liberation from the
solid support triggered a cyclization to the 3,4-dihydro-2H-1,4-oxazine scaffold, followed by based-catalyzed lactonization
to the fused second ring. At prolonged reaction time, eliminative
cleavage occurred and monocyclic DKMs 25 were formed,
for example, from 24. An analogous protocol could be
used for the solid-phase-supported generation of tricyclic DKMs 29 (Scheme ).[20]
Reagents
and conditions: (a)
halocarboxylic acid, DIC, CH2Cl2; (b) TFA, CH2Cl2; (c) DIPEA, DMSO.An
N-terminal degradation of peptoid oligomers through sequential
cleavage of N-substituted glycine units was accomplished on a solid
phase.[21] The protocol relied on the treatment
of resin-bound bromoacetylated peptoids 31 with silver
perchlorate, leading to an intramolecular lactonization, releasing
the terminal residue as part of an N-substituted DKM 34, and resulting in the truncated peptoid 33 (Scheme ).
Scheme 9
Iterative Peptoid
Sequencing through DKM Liberation
Chemical
Reactivity and Utilization in Ring-Opening
Polymerizations
The chemical reactivity of DKMs has mainly
been explored to perform
ring-opening polymerization reactions (see below). In a model transformation,
N-substituted, racemic DKMs 35 were treated with ethanolic
ammonia to undergo ring opening to diamides 36 (Scheme ). The second step leading
to intermediates 37 occurred slower and involved the
intramolecular participation of the primary carboxamide moiety. The
imides 37 were susceptible to subsequent conversions
with nucleophiles.[22] The regioselective
course of the ring opening of 35 reflected the expected
higher electrophilic reactivity of the lactone group compared to that
of the lactam group in DKMs. The cleavage of a defined DKM with a
functionalized benzylamine was utilized for the preparation of a thrombin
inhibitor.[22]
Scheme 10
Ammonolysis of DKMs
to Diamides and Acyl Transfer to Imides
Reagents and conditions:
(a)
5 M NH3/EtOH, room temperature.
Ammonolysis of DKMs
to Diamides and Acyl Transfer to Imides
Reagents and conditions:
(a)
5 M NH3/EtOH, room temperature.Overall, the synthetic potential of DKMs to generate defined low-molecular
weight compounds with tailored properties has not yet been fully exploited.
In contrast, DKMs have been frequently utilized as monomers for polymerization
reactions.Polydepsipeptides are alternating copolymers of an
α-amino
and an α-hydroxy acid. They are valued for their nontoxic properties
and their degradability and are suitable for numerous applications,
such as tissue engineering and drug delivery. Compared to polypeptides,
polydepsipeptides do not necessarily require enzymes for their degradation
because of the hydrolytic susceptibility of the ester groups. The
presence of the carboxamide portions in polydepsipeptides allows for
strong intramolecular hydrogen bond interactions, in contrast to polyesters.
These hydrogen bonds influence their mechanical and thermal properties,
which can be fine-tuned by variations of the amino acid moieties.
In particular, telechelic oligodepsipeptides, capable of entering
into further polymerization or other reactions through their reactive
terminal groups, serve as valuable building blocks for biomedical
applications.[3,23]Polydepsipeptides (38) are generally accessibly by
employing DKMs (1) in ring-opening polymerization reactions
(Scheme ). Several
attempts have been made to control copolymer compositions, molecular
weights, crystallinity, and degradability by using different polymerization
conditions.[10,23]
Scheme 11
Ring-Opening Polymerization
to Produce Polydepsipeptides from DKMs
Reagents and conditions:
(a)
Sn(Oct)2, CHCl3,[10] or BnOH, TBD or DBU, THF or CHCl3.[7,8]
Ring-Opening Polymerization
to Produce Polydepsipeptides from DKMs
Reagents and conditions:
(a)
Sn(Oct)2, CHCl3,[10] or BnOH, TBD or DBU, THF or CHCl3.[7,8]As a catalyst, stannous octoate (tin(II) 2-ethylhexanoate,
Sn(Oct)2) has frequently been used. Following the “coordination–insertion”
mechanism, a tin alkoxide is formed from Sn(Oct)2 and a
hydroxyl group of the initiator molecule, the carbonyl oxygen coordinates
the metal center, followed by the nucleophilic attack of the alkoxide
ligand and subsequent lactone bond cleavage, thus generating an analogous,
active species.[23] 1,5,7-Triazabicyclo[4.4.0]dec-5-ene
(TBD) was a particularly active catalyst for the generation of polymers 38 (R1 = H, R2 = H or alkyl) from corresponding
DKMs 1 using benzyl alcohol as an initiator.[7] Several bases, such as 1,8-diazabicyclo[5.4.0]undec-7-ene
(DBU), were investigated in polymerizations of methionine-derived
DKMs 1 (R1 = H or alkyl, R2 = CH2CH2SCH3).[8] The resulting poly(ester amides) 38 were applicable
for postpolymerization modifications via “methionine click”
chemistry.[8,24]DKMs could be copolymerized with substituted
glycolides (3, Figure ) or lactones such as ε-caprolactone to achieve
copolymers
with tailored properties.[10,23] A detailed description
has been provided elsewhere.[23] Instead
of Sn(Oct)2 as the catalyst and ethylene glycol as the
initiator,[23] a single Sn(IV) organotin
compound could perform both tasks. 2,2-Dibutyl-1,3,2-dioxastannolane,
prepared from dibutyltin oxide and ethylene glycol, was employed in
the ring-opening polymerization to prepare 39 (Scheme ).[3] The softness of the metal catalyst influenced the outcome
of the polymerization, and Fe(OAc)2 performed best among
non-Sn(Oct)2 catalysts in ring-opening polymerizations
with different DKMs and 1,8-octanediol as an initiator.[9] Block copolymers 41 were synthesized
by means of ring-opening polymerization with 3-methylmorpholine-2,5-dione
(40) and an amino-terminated polyethylene glycol (PEG)
as an initiator.[23]
Scheme 12
Generation of Block
Polymers by Ring-Opening Polymerization Reactions
of DKMs
Reagents and conditions: (a)
Sn(Oct)2, ethylene glycol, 140 °C;[23] or (1) dibutyltin oxide, ethylene glycol, (2) bulk, 140
°C;[3] (b) Jeffamines ED-600, ED-900,
or ED-2001, THF, 140 °C.[23]
Generation of Block
Polymers by Ring-Opening Polymerization Reactions
of DKMs
Reagents and conditions: (a)
Sn(Oct)2, ethylene glycol, 140 °C;[23] or (1) dibutyltin oxide, ethylene glycol, (2) bulk, 140
°C;[3] (b) Jeffamines ED-600, ED-900,
or ED-2001, THF, 140 °C.[23]DKMs are expected to be involved in the chemical
evolution from
amino acids to peptides. Model prebiotic molecules were generated
from monomers by wet–dry cycling experiments and DKMs such
as 61 identified in the obtained mixtures, in addition
to depsipeptides, polyesters, peptides, and yet unreacted hydroxy
and amino acids (Scheme ).[25]
Scheme 13
DKM 61 as an Intermediate in a Proposed Pathway to Trimeric
Prebiotic Compounds
Natural
Products
Monocyclic DKMs have been reported as natural products.
Examples
are shown in Figure . Enniatins are mixtures of cyclic hexadepsipeptides found in Fusarium fungi. Enniatin B forms an 18-membered ring
composed of each three alternating N-methyl-(S)-valine and (R)-2-hydroxy-3-methylbutanoic
acid building blocks. The DKM congeners 42–44, supposed side products of the nonribosomal enniatin B
biosynthesis, were isolated from Fusarium sporotrichioides (Figure ).[12] DKM 42, which contained the two
enniatin B building blocks, was present in prevailing amounts in the
broth and mycelium of Fusarium sporotrichioides, whereas the production of 43 and 44 was
presumably due to low substrate specificity of the enniatin synthetase
for (S)-amino acids.[12] Compound 42 exhibited inhibitory properties against
xanthine oxidase and anti-inflammatory activity in human peripheral
blood mononuclear cells.[26] Aliphatic DKM
derivatives such as 42 and 43 have been
evaluated with respect to their antimicrobial, antioxidant, immunomodulatory,
and antiproliferative activities.[1,26]
Figure 2
Monocyclic
DKMs from natural sources.
Monocyclic
DKMs from natural sources.Bassiatin (45) was isolated from the cultured broth
of the entomopathogenic sac fungus Beauveria bassiana, in addition to depsipeptides of a higher oligomerization state
such as the cyclic hexadepsipeptide beauvericin.[27] Bassiatin possessed insecticidal activities against Bemisia tabaci, a whitefly and important agricultural
pest, in contact and feeding assays. Bassiatin inhibited the ADP-induced
platelet aggregation.[27] A diastereomer
(46) from the sac fungus Isaria japonica induced apoptotic cell death in human leukemia cells in the micromolar
range.[27] DKM 47 was identified
as a constituent of the traditional Chinese medicine Bombyx batryticatus, the dried dead larva of silkworms
after infection by Beauveria bassiana.[27] DKM 48 was isolated from
the sea hare Bursatella leachii.[27] Other DKMs bearing N-benzyl
substituents have been synthesized and investigated as inhibitors
of glucosidases, as summarized elsewhere.[1]The greater propensity of proline and N-methyl-substituted
amino acids to adopt a cis conformation and the consequent
preferred DKM cyclization might account for the more frequent appearance
of bicyclic DKMs such as 61 (Scheme )[25] and N-methyl-substituted DKMs such as 42–48 (Figure ).DKMs are substructures of naturally occurring polycyclic
indole
alkaloids. Respective natural products mainly contain a diketopiperazine
ring fused to the terminal five-membered ring of the pyrrolidinoindoline
system.[5] However, there are also natural
products in which a DKM unit replaced the diketopiperazine core. Such
tetracyclic compounds (49–58) are
depicted in Figure . Mollenines A (49) and B (50) were isolated
from the sclerotioid ascostromata of Eupenicillium
molle.[28] The total synthesis
of 49 was realized either by the preparation of a prenylated
pyrrolidinoindoline ester from tryptophan and the final connection
with leucic acid[6] or by a one-pot reaction
of the DKM composed of tryptophan and leucic acid with a vinyl cyclopropane
reagent.[28] Mollenine A possessed cytotoxic
and antibacterial activity against Bacillus subtilis.[28] Javanicunines A (51)
and B (52) are isoprenylated DKM alkaloids isolated from
the extract of Eupenicillium javanicum.[28] The key step of the synthetic access
to these DKMs was the linkage of the prenylated pyrrolidinoindoline
ester with leucic acid followed by lactonization.[5] Recently, similar DKM natural products, such as deacetyl-javanicunine
A (54), javanicunine C (53), and javanicunine
D (55), were identified from a Penicillium species.[28]
Figure 3
Polycyclic natural products
with a fused DKM ring.
Polycyclic natural products
with a fused DKM ring.The DKM alkaloids PF1233
B, also referred to as shornephine A (56) and 9-deoxy-PF1233
A (57) and B (58), were identified from
marine-sediment-derived Aspergillus species.[4] Methanolysis of 56 occurred at the lactone moiety and led to the opening of the DKM
cycle.[4] The total synthesis of 57 and 58 was accomplished via an epoxidation of the intermediate
DKM containing a tryptophan and leucic acid moiety. Subsequent intramolecular
epoxide opening led to the tetracyclic scaffold.[5] PF1233 B (56) was reported as a noncytotoxic
inhibitor of P-glycoprotein transporters, key mediators of drug efflux
in multi-drug-resistant human cancer cells.[4] Clonorosin A (59) with the DKM ring fused to a tetracyclic
isoindolo[4,5,6-cd]indole system was isolated from
the soil-derived fungus Clonostachys rosea. It showed activity against Fusarium oxysporum, an ascomycete fungus which is pathogenic to plants.[29]Further DKM alkaloids such as acu-dioxomorpholines
from the fungus Aspergillus aculeatus were identified using a fungal
artificial chromosome and metabolomic scoring platform. Due to this
technology, the DKM biosynthetic pathway was elucidated, and nonribosomal
peptide synthetase gene clusters responsible for the production of
DKM alkaloids were characterized.[30]
Conclusions
Despite the striking simplicity of the
diketomorpholine structure,
this chemotype has received less general attention than expected.
This review highlights the various synthetic routes to DKMs and their
chemical reactivity, in particular, in the application of ring-opening
reactions leading to tailored polymers. Furthermore, compounds bearing
the DKM scaffold are represented among natural products, particularly
fungal metabolites. Naturally occurring DKMs comprise small, monocyclic
compounds but also complex alkaloids with a fused DKM substructure.
Obviously, the class of DKMs still has not been fully explored and
gives space for further research and application. Hence, this review
might encourage scientists to increasingly take account of several
aspects of diketomorpholine synthetic and natural product chemistry
for their own research.
Authors: G M Cingolani; A Di Stefano; B Mosciatti; F Napolitani; G Giorgioni; M Ricciutelli; F Claudi Journal: Bioorg Med Chem Lett Date: 2000-06-19 Impact factor: 2.823